Acute generalised exanthematous pustulosis

The Australasian Journal of Dermatology
Suran L Fernando

Abstract

Acute generalised exanthematous pustulosis (AGEP) is a severe cutaneous adverse reaction and is caused by drugs in >90% of cases. It is rare, with an incidence of 1-5 patients per million per year. The clinical manifestations are characterised by fever and the rapid appearance of disseminated sterile pustules 3-5 days after the commencement of treatment. It is accompanied by marked neutrophilia. Mucous membranes are not typically involved. The drugs conferring the highest risk of AGEP according to the EuroSCAR study are aminopenicillins, pristinamycin, hydroxychloroquine, antibacterial sulphonamides, terbinafine and diltiazem. The pathogenesis of AGEP involves the initial influx of CD8 cytotoxic T-cells resulting in the apoptosis of keratinocytes and formation of vesicles. Then CXCL-8-producing and granulocyte macrophage-colony stimulating factor-producing CD4 cells enter the epidermis, resulting in neutrophil mediated inflammation and the formation of pustules. As a result, the histology reveals intraepidermal, usually subcorneal, pustules and an accompanying neutrophilic and lymphocytic infiltrate. Epicutaneous patch testing may also support the diagnosis by causing a localised pustular reaction 48-96 h after the offending dr...Continue Reading

References

Jan 1, 1986·Dermatologica·B RouchouseA L Claudy
Oct 1, 1996·International Journal of Dermatology·V Haro-GabaldónR Naranjo-Sintes
Jun 2, 1998·Rheumatic Diseases Clinics of North America·S J Naides
Feb 13, 2001·Journal of Cutaneous Pathology·A SidoroffJ C Roujeau
Jun 8, 2001·The Journal of Clinical Investigation·M BritschgiW J Pichler
Sep 25, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Vincent M BrandenburgBernhard Heintz
Dec 6, 2002·The American Journal of Pathology·Simone SchmidWerner J Pichler
Jul 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Patrick SchaerliWerner J Pichler
Mar 16, 2005·Toxicology·Jean-Claude Roujeau
Aug 16, 2006·Journal of the American Academy of Dermatology·Batya B DavidoviciUNKNOWN RegiSCAR study group
Aug 22, 2006·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·S ManzanoB Laubscher
May 28, 2008·The British Journal of Dermatology·A J Birnie, S M Litlewood
Jul 5, 2008·Contact Dermatitis·Hichem BelhadjaliJameleddine Zili
Sep 6, 2008·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·N KleinA Enk
Aug 18, 2010·Archives of Dermatology·Yi-Chun ChenChia-Yu Chu

❮ Previous
Next ❯

Citations

Jul 12, 2013·Paediatric Drugs·Kara Heelan, Neil H Shear
Jul 16, 2014·Immunology and Allergy Clinics of North America·Young-Min YeHae-Sim Park
Dec 18, 2015·European Journal of Internal Medicine·Angelo V MarzanoMassimo Cugno
Feb 26, 2013·Cutaneous and Ocular Toxicology·Hakan TuranCihangir Aliagaoglu
Feb 3, 2016·Clinical Medicine : Journal of the Royal College of Physicians of London·Ying Xin Teo, Sarah Anne Walsh
Apr 8, 2015·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Valeria BoccalettiSergio Di Nuzzo
Jan 21, 2015·Annals of Emergency Medicine·Shawna D Bellew, Tobias Kummer
Jan 9, 2015·Indian Journal of Dermatology, Venereology and Leprology·Sedef BayataPeyker Temiz
Sep 1, 2016·Anais Brasileiros De Dermatologia·Laura de Mattos MilmanGerson Vettorato
Jun 27, 2014·Annals of Dermatology·Deborah LeeHo Suk Sung
Nov 20, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Anna E PowerIngrid Hopper
Mar 4, 2017·The British Journal of Dermatology·N R AdlerE J Phillips
Apr 1, 2016·Melanoma Research·Shelley J E HwangPablo Fernandez-Penas
Aug 30, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Jenana H MakerStephanie F James
May 23, 2018·Dermatologic Therapy·Casey L RossKiran Motaparthi
Aug 13, 2017·Drugs & Aging·James W S Young, Neil H Shear
Nov 2, 2019·Annales de dermatologie et de vénéréologie·J-L Bourrain
Aug 4, 2021·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Suran L FernandoChristopher Weir

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Allergology International : Official Journal of the Japanese Society of Allergology
Michael MakrisDimitrios Kalogeromitros
International Journal of Dermatology
Roberto Rheingantz da Cunha FilhoJosé Fillus Netto
© 2021 Meta ULC. All rights reserved